(Q34386021)

1 August 2017

1 reference

title

Artemisinin and its derivatives: an important new class of antimalarial agents (English)

1 reference

1 August 2017

0 references

0 references

Balint GA

1

1 reference

1 August 2017

publication date

1 May 2001

1 reference

Pharmacology & Therapeutics

1 August 2017

published in

1 reference

1 August 2017

volume

90

1 reference

1 August 2017

issue

2-3

1 reference

1 August 2017

page(s)

261-265

1 reference

Artemisinin pharmacokinetics in healthy adults after 250, 500 and 1000 mg single oral doses

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900140-1

7 January 2021

Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900140-1

7 January 2021

Comparison of artemether and quinine in the treatment of severe falciparum malaria in south-east Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900140-1

7 January 2021

Qinghaosu (artemisinin): an antimalarial drug from China

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900140-1

7 January 2021

Metabolism of antimalarial sesquiterpene lactones.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900140-1

7 January 2021

An open randomized trial of artemether versus quinine in the treatment of cerebral malaria in African children

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900140-1

7 January 2021

Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900140-1

7 January 2021

Efficacy of artemether in severe falciparum malaria in African children

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900140-1

7 January 2021

Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900140-1

7 January 2021

10.1016/S0163-7258(01)00140-1

Identifiers

DOI

1 reference

1 August 2017

1 reference